System, a Public Benefit Corporation building a quantitative model of the world as one interconnected system, has received a $6.5 million program-related investment from Wellcome Trust. This marks one of the foundation's first such investments in public interest technology. The funding will enable System to release the System Graph into the commons, develop open-source tools for researchers, and build a global community of systems thinkers. The System Graph aims to organise data and knowledge across traditional silos like disciplines and scales. Under the agreement, System must maintain its Public Benefit Corporation status for five years and cannot materially change its mission without Wellcome's approval. Founder and CEO Adam Bly said the investment ensures the company's mission remains durable and sustainable whilst driving systems-based research and solutions globally.

TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI) announced today it has received FDA 510k Clearance (K240297) for the Canady Helios Cold Plasma™ (CHCP) Ablation System for the ablation of soft tissue during surgery. The CHCP system consists of the Canady Helios Cold Plasma XL-1000 CP Smart Electrosurgical Generator, Canady Helios Cold Plasma Ablators, Foot Pedal and Trolley Cart. Plasma is the fourth state of matter formed by ionizing neutral gases (i.e. Argon or Helium) combined with electromagnetic fields. The Canady Helios Cold Plasma™ System introduces a novel approach to soft tissue ablation using plasma. The system creates a plasma jet consisting of a pre-programmed, pulsed, non-contact, non-thermal (24 C to 30 C), three-dimensional, Plasma Treated Electromagnetic Field™ (PTEF)